Literature DB >> 22807513

The case for combined-modality therapy for limited-stage Hodgkin's disease.

Christine E Hill-Kayser, John P Plastaras, Zelig Tochner, Eli Glatstein.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22807513      PMCID: PMC3425517          DOI: 10.1634/theoncologist.2012-0148

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  10 in total

1.  ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.

Authors:  Ralph M Meyer; Mary K Gospodarowicz; Joseph M Connors; Robert G Pearcey; Woodrow A Wells; Jane N Winter; Sandra J Horning; A Rashid Dar; Chaim Shustik; Douglas A Stewart; Michael Crump; Marina S Djurfeldt; Bingshu E Chen; Lois E Shepherd
Journal:  N Engl J Med       Date:  2011-12-11       Impact factor: 91.245

2.  Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Authors:  Andreas Engert; Annette Plütschow; Hans Theodor Eich; Andreas Lohri; Bernd Dörken; Peter Borchmann; Bernhard Berger; Richard Greil; Kay C Willborn; Martin Wilhelm; Jürgen Debus; Michael J Eble; Martin Sökler; Antony Ho; Andreas Rank; Arnold Ganser; Lorenz Trümper; Carsten Bokemeyer; Hartmut Kirchner; Jörg Schubert; Zdenek Král; Michael Fuchs; Hans-Konrad Müller-Hermelink; Rolf-Peter Müller; Volker Diehl
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

3.  Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?

Authors:  Dan L Longo
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

Review 4.  Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma.

Authors:  Christine Herbst; Fareed Ahmed Rehan; Nicole Skoetz; Julia Bohlius; Corinne Brillant; Holger Schulz; Ina Monsef; Lena Specht; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 5.  Breast cancer in women after treatment for Hodgkin's disease.

Authors:  Kenan Deniz; Susan O'Mahony; Gillian Ross; Anand Purushotham
Journal:  Lancet Oncol       Date:  2003-04       Impact factor: 41.316

6.  Clinical evaluation and radiotherapeutic management of Hodgkin's disease and the malignant lymphomas.

Authors:  H S Kaplan
Journal:  N Engl J Med       Date:  1968-04-18       Impact factor: 91.245

7.  Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

Authors:  Shira L Galper; James B Yu; Peter M Mauch; Jon F Strasser; Barbara Silver; Ann Lacasce; Karen J Marcus; Mary Ann Stevenson; Ming Hui Chen; Andrea K Ng
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

8.  Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

Authors:  Marie L De Bruin; Lucille D A Dorresteijn; Mars B van't Veer; Augustinus D G Krol; Helena J van der Pal; Arnoud C Kappelle; Willem Boogerd; Berthe M P Aleman; Flora E van Leeuwen
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 13.506

9.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Authors:  Lois B Travis; Deirdre A Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars B Van't Veer; Ingrid Glimelius; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle Curtis; John D Boice; Ethel Gilbert
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

10.  Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.

Authors:  R C Young; G P Canellos; B A Chabner; S M Hubbard; V T DeVita
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

  10 in total
  2 in total

1.  The case for chemotherapy alone for limited-stage Hodgkin's lymphoma.

Authors:  Joseph M Connors
Journal:  Oncologist       Date:  2012-07-17

2.  Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

Authors:  Theodoros P Vassilakopoulos; Georgios Boutsikas; Vassilios Papadakis
Journal:  Transl Pediatr       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.